Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00130195
Status:
COMPLETED
Last Update Posted:
2008-11-14
First Post:
2005-08-12
Brief Title:
Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia ALL
Sponsor:
Japan Adult Leukemia Study Group
Organization:
Japan Adult Leukemia Study Group
Organization Data
Organization:
Japan Adult Leukemia Study Group
Class:
OTHER
Study ID:
JALSG PhALL202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Japan Adult Leukemia Study Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None